Elicio Therapeutics
Elicio Therapeutics develops off-the-shelf cancer immunotherapies using its AMP technology platform.
8-KSep 14Latest SEC filing, period to Sep 14
Aug 13Latest story
August 2026
July 2026
Sign inSign inElicio Therapeutics develops off-the-shelf cancer immunotherapies using its AMP technology platform.